Cervical cancer remains a significant public health challenge in Kenya, ranking as the second most common cancer among women and the leading cause of cancer-related deaths in the country.
Annually, about 5,236 women are diagnosed with cervical cancer, and approximately 3,211 die from the disease.
This means nearly nine Kenyan women lose their lives to cervical cancer every day. Despite being preventable, this disease continues to devastate lives due to limited access to screening, vaccination and treatment.
This January, which is the Cervical Cancer Awareness Month, offers an opportunity to amplify efforts to end this preventable disease.
The 2025 theme emphasises the power of vaccines and early detection, urging governments, communities and individuals to take action.
The human papillomavirus (HPV) vaccine is a game-changer in cervical cancer prevention, with research showing that vaccinating girls aged nine to 14 years can significantly reduce the risk.
However, vaccine coverage in Kenya remains low, compounded by misinformation and logistical challenges.
Public education is crucial to close this gap. While 75 per cent of women are aware of cervical cancer, only 14 per cent undergo regular screenings.
Increasing awareness through media campaigns, schools, and community initiatives can dispel myths, encourage early detection and reduce stigma.
Strengthening healthcare systems to offer accessible and affordable services, including screenings and follow-up care, is vital.
The World Health Organization’s strategy to eliminate cervical cancer targets 90 per cent HPV vaccination coverage, 70 per cent screening by mid-life and 90 per cent treatment.
Kenya is making strides with HPV vaccination and integrating cervical cancer care into reproductive health services. However, sustained funding, political will and community participation are essential to meet these goals.
